Hanefeld M, Weck M
Lipid Research Unit, Medical Clinic, Dresden, German Democratic Republic.
Int J Obes. 1989;13 Suppl 2:33-7.
VLCD is an effective and safe measure to reduce overweight in NIDDM. It substantially improves glucose control and corrects associated coronary risk factors, in particular dyslipoproteinaemia and hypertension. Both insulin secretion and insulin resistance were ameliorated by perfect glucose control with VLCD. Reliable data on long term efficacy and factors determining weight loss and success in permanent glucose control are urgently needed.